ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,048 | -82.8% | 26,967 | -71.8% | 0.00% | -100.0% |
| Q1 2023 | $720,982 | -72.5% | 95,621 | -63.0% | 0.00% | -78.6% |
| Q4 2022 | $2,618,777 | +411.5% | 258,517 | +399.4% | 0.01% | +366.7% |
| Q3 2022 | $512,000 | -64.9% | 51,767 | -65.4% | 0.00% | -75.0% |
| Q1 2022 | $1,457,000 | +418.5% | 149,417 | +659.5% | 0.01% | +500.0% |
| Q4 2021 | $281,000 | – | 19,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |